Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors.

Gordon, Michael S; Shapiro, Geoffrey I; Sarantopoulos, John; Juric, Dejan; Lu, Brian; Zarotiadou, Angeliki; Connarn, Jamie N; Le Bruchec, Yvan; Dumitru, Calin Dan; Harvey, R Donald.

Afiliação

Gordon MS; Departments of Hematology and Medical Oncology, HonorHealth Research Institute, Scottsdale, AZ, United States.
Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Sarantopoulos J; Department of Medicine, Division of Medical Oncology & Hematology, Institute for Drug Development, Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, United States.
Juric D; Massachusetts General Hospital Cancer Center, Boston, MA, United States.
Lu B; Department of Medicine, Harvard Medical School, Boston, MA, United States.
Zarotiadou A; Bristol Myers Squibb, Princeton, NJ, United States.
Connarn JN; Celgene Research S.L.U., a Bristol-Myers Squibb Company, Boudry, Switzerland.
Le Bruchec Y; Bristol Myers Squibb, Princeton, NJ, United States.
Dumitru CD; Bristol Myers Squibb, Princeton, NJ, United States.
Harvey RD; Bristol Myers Squibb, Princeton, NJ, United States.